Compugen

Compugen is a world leader in the development and utilization of advanced computational technologies to model and understand the molecular mechanisms of life. The application of the company's technology has led to the creation of a pipeline of more than 4000 novel human genes and an additional 10,000 novel sequences with identified putative functions. From this database, which is being enlarged on an on-going basis, selected genes with anticipated pharmaceutical relevance are being further developed by Compugen, using its in-house molecular biology capabilities, or licensed to other companies for development and commercialization. Compugen Inc., its U.S. based subsidiary including customer support, R&D and business development, is headquartered in Jamesburg, New Jersey.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: